Home › Experimental Cervical Cancer Vaccine Looks Promising in Trial
 

Keywords :   


Experimental Cervical Cancer Vaccine Looks Promising in Trial

2014-10-02 06:35:36| Biotech - Topix.net

An experimental vaccine meant to protect against nine types of human papillomavirus could prevent 90 percent of all cervical cancers, a new study suggests. Researchers examined data from more than 2,500 women with precancerous cervical lesions and found that nearly all were caused by the nine types of HPV targeted by the vaccine being developed by Merck and Co.

Tags: trial cancer experimental promising

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
14.05Biden hits Chinese electric cars with higher tariffs
14.05University of Sydney Researchers Working on Potential New Use For Landfill Gas
14.05Niyeti Shah Advocates for Better Food Systems
14.05True Corporation has releases 1Q 2024 results
14.05FuboTV releases results for quarter ended March 31, 2024
14.05IDC forecasts slower growth for global telecoms market
14.05Chunghwa Telecom reports results for the first quarter of 2024
14.05Indorama Ventures Reports Improved Performance in 1Q 2024
More »